Tag: Japan

Classico Pokemon Collection: “Stay with Your Favorite Pokemon Everywhere”

TOKYO, June 8, 2026 /PRNewswire/ -- Classico, Inc., a Japanese medical apparel brand headquartered in Tokyo, launched the highly anticipated #ClassicoPokemonCollection across the Asian...

TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia

BANDUNG, Indonesia, June 8, 2026 /PRNewswire/ -- TotalEnergies ENEOS successfully completed Phase 2 of a rooftop solar photovoltaic (PV) project with PT. Perusahaan Industri Ceres...

GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company

Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas

Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

VESALIUS-CV Subgroup Results Show Repatha® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk DiabetesNew Real-World Data Highlight Treatment...

Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while...

Company announcement No. 21 / 2026

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting...

Ingelheim, Germany - Boehringer Ingelheim today announced positive results from two global Phase III trials of its glucagon/GLP-1 dual agonist survodutide (BI 456906), SYNCHRONIZE-1 and SYNCHRONIZE-MASLD.^2,4 The results demonstrate survodutide’s potential to reduce weight and therefore improve metabolic health in two distinct populations: adults living with obesity or overweight, without type 2 diabetes (SYNCHRONIZE-1),²and adults with overweight or obesity with metabolic dysfunction-associated steatotic liver disease (MASLD) with evidence of inflammation and or fibrosis (SYNCHRONIZE-MASLD).⁴ Full results from SYNCHRONIZE-1 and SYNCHRONIZE-MASLD were presented today at the American Diabetes Association’s (ADA) 2026 Scientific Sessions and published simultaneously in The New England Journal of Medicine and Nature Medicine respectively.^5,6

CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF ¥84,200,000,000 Japanese Yen Callable Senior Non-Preferred Bonds issued on June 3, 2021 (ISIN: JP525022AM69)

Montrouge, June 8, 2026

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage...

In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4 lbs (14.4%) and those in post-menopause lost up to 28.2 lbs (14.1%)In ATTAIN-2, women taking Foundayo lost significant...

GreenCore Solutions Corp. (GSC) Signs Multi-Year Asia BPC Supply Deal as Inbound Agent Traffic Hits Record Levels — Asia-Pacific Crosses 1 Million Inbound Agent...

GSC AI Agent Stack traffic up 207% quarter-over-quarter in 50 primary global marketsTORONTO, June 5, 2026 /PRNewswire/ - GreenCore Solutions Corp. ("GSC") today announced...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsJapan

RMG ML Sports Holdings Announces the Pricing of $200 Million Initial Public Offering

Ramaco Resources to Participate in StoneX Fourth Annual Natural Resources Summit

MNA: Brigham Nurses to Hold Strike Authorization Vote as Mass General Brigham Contract Proposals Undermine Safe Patient Care and the BWH Nursing Workforce

Tag: Japan

Classico Pokemon Collection: “Stay with Your Favorite Pokemon Everywhere”

TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia

GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while...

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting...

CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF ¥84,200,000,000 Japanese Yen Callable Senior Non-Preferred Bonds issued on June 3, 2021 (ISIN: JP525022AM69)

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage...

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Global Rise in Delayed Childbearing and Infertility Drives Demand for Cross-Border Fertility Care

Quantinuum Announces Closing of Upsized Initial Public Offering

Quantinuum Announces Closing of Upsized Initial Public Offering

Quantinuum Announces Closing of Upsized Initial Public Offering

GreenCore Solutions Corp. (GSC) Signs Multi-Year Asia BPC Supply Deal as Inbound Agent Traffic Hits Record Levels — Asia-Pacific Crosses 1 Million Inbound Agent...

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us